Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Kefir

What does the research say about Kefir?

2 health outcomes synthesised

Research has investigated kefir for 2 health outcomes, primarily related to metabolic health. The strongest evidence supports its role in reducing HOMA-IR, with all 3 studies reporting beneficial effects. No specific effective dose or population insights are available from the current evidence.

Strongest evidence: The most robust evidence is for reducing HOMA-IR, with moderate evidence strength. All 3 studies (including 2 meta-analyses and 1 RCT) reported beneficial effects, though effect sizes ranged from small to large. The median study duration was 84 days.

Mixed or weaker evidence: For reducing fasting blood glucose, evidence is low. Two of 3 meta-analyses found a moderate beneficial effect, while one neutral meta-analysis (larger sample, higher quality) found no significant effect. This inconsistency limits confidence.

Effective dose patterns: No effective dose information was reported in the syntheses; both outcomes have null effective dose data.

Population insights: No specific population insights were identified across the studies.

Notable caveats: The evidence base is small (only 3 studies per outcome), making conclusions preliminary. Publication bias is a concern, especially for HOMA-IR where null results are less likely to be published. For HOMA-IR, one RCT found no significant difference versus unfermented milk. For fasting glucose, the single neutral meta-analysis had higher quality and larger sample size, raising questions about the overall benefit.

Frequently asked

  • What is Kefir good for according to research?
    Kefir has been studied for two metabolic outcomes. The strongest evidence indicates it may help reduce HOMA-IR (a measure of insulin resistance), with all 3 studies reporting beneficial effects. Evidence for lowering fasting blood glucose is mixed, with 2 of 3 meta-analyses showing benefit.
  • What dose of Kefir is typically used in studies?
    The syntheses did not report specific effective doses. Study durations ranged up to 84 days, but no standardized dosing information was available.
  • Who benefits most from Kefir?
    No specific populations (e.g., by age or baseline health) were identified in the research syntheses. The studies included general adult populations, but subgroup analyses were not reported.
  • Are there caveats or limitations in the research on Kefir?
    Yes. The evidence base is small (only 3 studies per outcome), so conclusions are preliminary. Publication bias is a concern, especially for HOMA-IR. Additionally, one randomized trial found no significant difference between kefir and unfermented milk for HOMA-IR, suggesting the effect may be small or confounded.
  • Does Kefir help reduce HOMA-IR?
    All 3 studies reported beneficial effects on HOMA-IR, with effect sizes ranging from small to large. Two meta-analyses found large reductions, while one RCT observed a small within-group decrease not significant versus placebo. Overall evidence is moderate.
  • Does Kefir help reduce fasting blood glucose?
    Evidence is mixed. Two of 3 meta-analyses found a moderate beneficial effect, but one neutral meta-analysis with a larger sample size and higher quality found no significant effect. The overall evidence strength is low.

Most-studied combinations with Kefir

most supplement research is combination research
Also studied with:Milk (2)

  • RAW Probiotics, Ultimate Care

    By Garden of Life

    4.6 (1.5K reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $41.99
    		In
    Vitacost
    $41.99
    		In
    Vitamin Shoppe
    $48.99
    		In
Back to top